Supplementary Figure 4:
Loss of heterozygosity patterns for BRCA1 and BRCA2 deleterious missense variants. Shown are variant allele frequencies in tumor (blue bars) and normal (red bars) sample pairs with rare deleterious variants scored by Condel. BRCA1 missense variants p.G1788V and p.R1699W were reported as clinically relevant in various BIC and HGMD mutation databases.
Supplementary Figure 5: Empirical distributions for the null hypothesis of
Variant Allele Frequency (VAF) differences between tumor and normal Samples. We constructed the distribution for all 3,635 observed events using both bootstrap resampling (with replacement) for one million through 100 million trials and full enumeration of all possible 3635 2 possible tumor-normal-matched events in the sample space. Corrections were made for purity by Equation (1). All methods give a very similar distribution, which reports that a 20% Variant Allele Frequency difference has roughly a 23% false-positive rate (i.e. 23% of the total area under the curve is to the right of the purple threshold).
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